CHRONIC MYELOID LEUKEMIA (CML)
Clinical trials for CHRONIC MYELOID LEUKEMIA (CML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOID LEUKEMIA (CML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOID LEUKEMIA (CML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for CML patients with Hard-to-Treat mutation?
Disease control Recruiting nowThis phase 2 trial is testing the drug asciminib in 20 adults with chronic myeloid leukemia who have a specific genetic change (T315I mutation) and cannot take the standard drug ponatinib. The goal is to see if asciminib can control the leukemia and improve outcomes. Participants…
Matched conditions: CHRONIC MYELOID LEUKEMIA (CML)
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could dead donors provide Life-Saving bone marrow?
Disease control Recruiting nowThis early study is testing whether bone marrow from deceased donors can be safely used for transplants in people with blood cancers like leukemia and lymphoma. Twelve patients will receive the transplant along with chemotherapy or radiation. The main goal is to see if the new ma…
Matched conditions: CHRONIC MYELOID LEUKEMIA (CML)
Phase: PHASE1, PHASE2 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
2000 CML patients to rate their care in landmark Quality-of-Life study
Knowledge-focused Recruiting nowThis study will ask 2000 adults with chronic myeloid leukemia (CML) in Lombardy, Italy, about their quality of life and how their hematology clinic is organized. Researchers want to see if different care models lead to better patient well-being. No new drugs or treatments are bei…
Matched conditions: CHRONIC MYELOID LEUKEMIA (CML)
Sponsor: University of Milano Bicocca • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:51 UTC